GlassScriptPhysician profile
Muhammad Ijaz Pervez
NPI 1225481443
$7,151.33
in general payments reported to CMS, 2019-2025
9 companies · $6,844 in 2025
The $6,844 reported for 2025 was more than what 93% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $17.82 · 2023: $18.39 · 2024: $272 · 2025: $6,844.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $4,000 · Travel and Lodging: $1,855 · Food and Beverage: $679 · Education: $599.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $4,000.00 |
| Travel and Lodging | $1,854.65 |
| Food and Beverage | $679.47 |
| Education | $599.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,182.75 | 2025 | Resolute Onyx |
| Philips North America LLC | $1,655.16 | 2025 | Igt Devices Undivided |
| Abbott Laboratories | $433.36 | 2024-2025 | Ensite, Aveir |
| W. L. Gore & Associates, INC. | $340.65 | 2025 | Gore Cardioform Asd Occluder |
| Boston Scientific Corporation | $245.59 | 2025 | General - Vascular Access |
| Penumbra, INC. | $143.00 | 2025 | Indigo System |
| Edwards Lifesciences Corporation | $114.61 | 2025 | Pascal |
| Lantheus Medical Imaging, INC. | $18.39 | 2023 | Definity |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Pervez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.